5-Hydroxy-3-methylindole

CAS : 1125-40-2

Ref. 3D-FH13802

Informations sur le produit

• Nom: 5-Hydroxy-3-methylindole
• Synonymes: 1H-indol-5-ol, 3-methyl-, 3-Methyl-5-hydroxyindole, 5-Hydroxyskatole, Indol-5-ol, 3-methyl-, Lumogen no. 1

Description

5-Hydroxy-3-methylindole (5HMI) is a metabolite of the drug tamoxifen, which is used for the treatment of breast cancer. It is also found in urine samples and has been shown to be reactive with cytochrome P450 2E1 (CYP2E1). 5HMI has been shown to inhibit the activity of CYP2E1 in humans, rats, and mice. 5HMI has also been shown to have anti-epileptic properties in epileptics. This active form is metabolized by adipose tissue or liver cells through oxidation and conjugation with glucuronic acid. The human liver cells show constitutive androstane receptor (CAR) activation, which may be due to its ability to act as an agonist or partial agonist.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 147.17 g/mol
• Formule: C₉H₉NO
• Degré de pureté: Min. 96%
• Couleur/Forme: Powder
• InChI: InChI=1S/C9H9NO/c1-6-5-10-9-3-2-7(11)4-8(6)9/h2-5,10-11H,1H3
• Code InChI: InChIKey=NPHFOFOYWYLBTF-UHFFFAOYSA-N
• SMILES: Cc1c[nH]c2ccc(O)cc12